GT200500224A - Proceso para la sìntesis de indoles n-alquilados c-2, c-3 sustituidos ùtiles como inhibidores de cpla2 - Google Patents

Proceso para la sìntesis de indoles n-alquilados c-2, c-3 sustituidos ùtiles como inhibidores de cpla2

Info

Publication number
GT200500224A
GT200500224A GT200500224A GT200500224A GT200500224A GT 200500224 A GT200500224 A GT 200500224A GT 200500224 A GT200500224 A GT 200500224A GT 200500224 A GT200500224 A GT 200500224A GT 200500224 A GT200500224 A GT 200500224A
Authority
GT
Guatemala
Prior art keywords
rented
indoles
synthesis
cpla2 inhibitors
useful substitutes
Prior art date
Application number
GT200500224A
Other languages
English (en)
Spanish (es)
Inventor
Ronald S Michalak
Mahmut Levent
Frederick J Vyverberg
Ara R Boyajian
Panolil Raveendranath
Michel Cantin
Alan Stockton
Michael W Winkley
Mousumi Ghosh
Christoph Dehnhardt
Charles Guinosso
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200500224A publication Critical patent/GT200500224A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/14Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GT200500224A 2004-08-19 2005-08-18 Proceso para la sìntesis de indoles n-alquilados c-2, c-3 sustituidos ùtiles como inhibidores de cpla2 GT200500224A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60312404P 2004-08-19 2004-08-19

Publications (1)

Publication Number Publication Date
GT200500224A true GT200500224A (es) 2006-03-21

Family

ID=35219553

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500224A GT200500224A (es) 2004-08-19 2005-08-18 Proceso para la sìntesis de indoles n-alquilados c-2, c-3 sustituidos ùtiles como inhibidores de cpla2

Country Status (24)

Country Link
US (3) US7582772B2 (cg-RX-API-DMAC7.html)
EP (1) EP1778629B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008510707A (cg-RX-API-DMAC7.html)
KR (1) KR20070043036A (cg-RX-API-DMAC7.html)
CN (2) CN101830837A (cg-RX-API-DMAC7.html)
AR (1) AR053410A1 (cg-RX-API-DMAC7.html)
AT (1) ATE517084T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005277392A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514431A (cg-RX-API-DMAC7.html)
CA (1) CA2576008A1 (cg-RX-API-DMAC7.html)
CR (1) CR8936A (cg-RX-API-DMAC7.html)
EC (1) ECSP077244A (cg-RX-API-DMAC7.html)
GT (1) GT200500224A (cg-RX-API-DMAC7.html)
HN (1) HN2005000474A (cg-RX-API-DMAC7.html)
IL (1) IL181364A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007002042A (cg-RX-API-DMAC7.html)
NO (1) NO20071253L (cg-RX-API-DMAC7.html)
PE (1) PE20060628A1 (cg-RX-API-DMAC7.html)
RU (1) RU2401829C2 (cg-RX-API-DMAC7.html)
SG (1) SG155214A1 (cg-RX-API-DMAC7.html)
SV (1) SV2006002200A (cg-RX-API-DMAC7.html)
TW (1) TW200609214A (cg-RX-API-DMAC7.html)
UA (1) UA85428C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006023611A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
TW200718687A (en) * 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2
CL2007003146A1 (es) * 2006-10-31 2008-01-25 Wyeth Corp Composición farmacéutica que comprende un compuesto derivado de indol y un sistema portador que comprende 15-25% de un mejorador de la viscosidad, 5-15% de un solubilizante, 10-50% de un diluyente y 1-10% de un estabilizante; proceso de preparación; y forma de dosificación.
WO2008055136A2 (en) * 2006-10-31 2008-05-08 Wyeth Liquid formulations of phospholipase enzyme inhibitors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02115157A (ja) * 1988-10-24 1990-04-27 Hokko Chem Ind Co Ltd スルホニルグリシン誘導体および除草剤
MXPA02005803A (es) * 1999-12-09 2003-02-27 Aventis Cropscience Gmbh Nitrosulfobenzamidas.
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
CN100503566C (zh) * 2001-12-03 2009-06-24 惠氏公司 细胞溶质磷脂酶a2抑制剂
US6635771B2 (en) * 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
US7101875B2 (en) * 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
US6984735B2 (en) * 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US6797708B2 (en) * 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
TW200510305A (en) * 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
CN1829684A (zh) 2003-07-29 2006-09-06 西巴特殊化学制品控股公司 3-芳基-2-氰基-3-羟基-丙烯酸衍生物
US7582771B2 (en) * 2003-09-03 2009-09-01 Wyeth Process for the synthesis of cPLA2 inhibitors
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) * 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles

Also Published As

Publication number Publication date
RU2007105231A (ru) 2008-09-27
ECSP077244A (es) 2007-03-29
BRPI0514431A (pt) 2008-06-10
UA85428C2 (ru) 2009-01-26
EP1778629B1 (en) 2011-07-20
US20090306428A1 (en) 2009-12-10
MX2007002042A (es) 2007-03-29
US20060041005A1 (en) 2006-02-23
JP2008510707A (ja) 2008-04-10
US7842837B2 (en) 2010-11-30
RU2401829C2 (ru) 2010-10-20
CR8936A (es) 2007-04-26
NO20071253L (no) 2007-05-15
US20110054189A1 (en) 2011-03-03
HN2005000474A (es) 2009-04-07
US8034960B2 (en) 2011-10-11
CN101006048B (zh) 2011-07-06
ATE517084T1 (de) 2011-08-15
PE20060628A1 (es) 2006-08-14
KR20070043036A (ko) 2007-04-24
IL181364A0 (en) 2007-07-04
SG155214A1 (en) 2009-09-30
WO2006023611A1 (en) 2006-03-02
TW200609214A (en) 2006-03-16
CN101830837A (zh) 2010-09-15
AR053410A1 (es) 2007-05-09
EP1778629A1 (en) 2007-05-02
CA2576008A1 (en) 2006-03-02
SV2006002200A (es) 2006-05-09
US7582772B2 (en) 2009-09-01
CN101006048A (zh) 2007-07-25
AU2005277392A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
ECSP11011008A (es) Proceso para la preparación de derivados de l-alanina protegidos
DOP2009000039A (es) COMPUESTOS DE PIRIDO (2,3-D) PIRIMIDINONA Y SU USO COMO INHIBIDORES DE P13-Ka
CY1113131T1 (el) Τα παραγωγα ινδολης ως αγωνιστες υποδοχεων s1p1
ECSP099817A (es) Procesos para la preparacion de pirazoles
HRP20130800T1 (en) Opioid receptor modulators
CY1112102T1 (el) Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1
SV2010003472A (es) Compuestos de pirazol
ECSP10010195A (es) Derivados de indolinona y procedimiento para su fabricación
CR20110467A (es) Derivados de benzofuranilo como inhibidores de la glucoquinasa
EA201070912A1 (ru) Производные оксима в качестве ингибиторов hsp90
NI201000198A (es) Compuestos triazina como inhibidores mtor y quinasa p13.
SV2010003598A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
CR10206A (es) Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
EA200702464A1 (ru) Способы получения фенольных 4-бифенилилазетидин-2-онов
ECSP088151A (es) Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
GT200600217A (es) Proceso para la sintesis de compuestos organicos
ECSP088251A (es) Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
ECSP077244A (es) Proceso para la síntesis de indoles n-alquilatados c-2, c-3 sustituidos útiles como inhibidores cpla2
PA8796801A1 (es) Sintesis quiral de diazepinoquinolinas
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
EA200900944A1 (ru) Новый способ получения кристаллической формы v агомелатина
EA201170526A1 (ru) Тиазолилпиразолопиримидины в качестве синтетических промежуточных соединений и связанные с ними способы синтеза
UY31398A1 (es) Proceso para sintetizar compuestos de ácido fosfónico y posfínico
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов
ECSP099599A (es) Procedimientos para la preparación de compuestos de urea sustituidos con piperidinilo